ADPD and CONY Evaluation Have your say on your journey to a new era in AD and help us tooSpecialty / RoleSelectNeurologistGeriatricianGeriatric psychiatristNurse practitionerPhysician associateNeurochemistNeuroradiologistPrimary care physicianOtherContinentSelectEuropeAsiaAfricaNorth AmericaSouth AmericaOceaniaHow would you rate the overall program (1=Poor to 10=Excellent)12345678910This activity…Strongly agreeAgreeDisagreeHas increased my knowledge in the topicHas increased my confidence in the topicHas increased my competencies relevant to my practice to improve patient careWill you make measurable change in your role?SelectYesPossiblyNot really, but it has reinforced my practiceNoIf Yes/Possibly select the changes you are likley to make I will test for AD biomarkers in the diagnostic work up of patients with early-stage AD I will be able to better identify patients who would benefit from amyloid-targeted therapies I will consider use of amyloid-targeted therapies in eligible patients with early-stage AD I will employ evidence-based management approaches for ARIA in my patients on amyloid-targeted therapies If No, which of the following are the biggest barriers to the diagnosis of early-stage AD? Lack of patient acceptance of invasive tests Lack of availability of testing at my practice Lack of effective therapies if diagnosis is positive Lack of data on the sensitivity and specificity of diagnosis testing Difficulty in discussing risks and benefits with patients Did you feel there was any bias in the educational content? No Yes (commercial) Yes (professional) Yes (personal) Would you recommend to a colleague? Yes No What topics would you like to see in the education programs we design for you?